Skip to main content
. Author manuscript; available in PMC: 2017 Dec 28.
Published in final edited form as: Semin Perinatol. 2014 Oct 1;38(8):503–507. doi: 10.1053/j.semperi.2014.08.015

Table 2.

Suggestions for future investigations of oseltamivir in pregnancy.

1. Additional PK analysis including well-matched non-pregnant controls
2. Delineation of PD end points and the impact of pregnancy on these end points
3. Exposure and outcome analyses
4. Impact of PK and PD alterations in pregnancy on viral resistance
5. Attention to the impact of maternal PK and PD alterations on neonatal outcomes